# Multimodal Drug Infiltration in Total Knee Arthroplasty: Is Posterior Capsular Infiltration Worth the Risk?

> **NCT02860949** · PHASE2 · COMPLETED · sponsor: **Thammasat University** · enrollment: 90 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** 0.5% bupivacaine 100 mg, morphine sulfate 5 mg, 0.1% epinephrine 0.6 mg, and ketorolac 30 mg mixed NSS up to 100 mL
- **PROCEDURE:** Drug injection at Anterior soft tissue (25 mL)+Medial gutter area (25 mL)+Lateral gutter area (25 mL)+Posterior capsular infiltration (25 mL)
- **PROCEDURE:** Drug injection at Anterior soft tissue (34 mL)+Medial gutter area (33 mL)+Lateral gutter area (33 mL

## Key facts

- **NCT ID:** NCT02860949
- **Lead sponsor:** Thammasat University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2016-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02860949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02860949, "Multimodal Drug Infiltration in Total Knee Arthroplasty: Is Posterior Capsular Infiltration Worth the Risk?". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02860949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*